Treatment of sonne dysentery.
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D004405:Dysentery, Bacillary / Q000188:drug therapy*; D005664:Furazolidone / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009268:Nalidixic Acid / Q000628:therapy; D009355:Neomycin / Q000627:therapeutic use; D010118:Oxytetracycline / Q000627:therapeutic use; D010303:Paromomycin / Q000627:therapeutic use; D012764:Shigella sonnei; D013223:Statistics as Topic; D013307:Streptomycin / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D013449:Sulfonamides; D009268:Nalidixic Acid; D005664:Furazolidone; D010303:Paromomycin; D002701:Chloramphenicol; D013752:Tetracycline; D009355:Neomycin; D010118:Oxytetracycline; D013307:Streptomycin